Jiefeng Cui

2.9k total citations
72 papers, 2.1k citations indexed

About

Jiefeng Cui is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Jiefeng Cui has authored 72 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Molecular Biology, 20 papers in Oncology and 15 papers in Cell Biology. Recurrent topics in Jiefeng Cui's work include Cancer Cells and Metastasis (10 papers), Cellular Mechanics and Interactions (9 papers) and Cancer, Hypoxia, and Metabolism (9 papers). Jiefeng Cui is often cited by papers focused on Cancer Cells and Metastasis (10 papers), Cellular Mechanics and Interactions (9 papers) and Cancer, Hypoxia, and Metabolism (9 papers). Jiefeng Cui collaborates with scholars based in China, Ethiopia and United States. Jiefeng Cui's co-authors include Rongxin Chen, Dongmei Gao, Zhenggang Ren, Yinying Dong, Yinkun Liu, Tong‐Chun Xue, Qiongdan Zheng, Xiahui Lin, Sifan Wu and Yang You and has published in prestigious journals such as Nature Communications, Blood and PLoS ONE.

In The Last Decade

Jiefeng Cui

72 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiefeng Cui China 29 1.0k 599 557 458 269 72 2.1k
Shuli Xia United States 29 1.7k 1.7× 497 0.8× 496 0.9× 171 0.4× 239 0.9× 66 2.6k
Shahriar Koochekpour United States 34 2.2k 2.2× 979 1.6× 723 1.3× 431 0.9× 246 0.9× 84 3.8k
Pierre de la Grange France 34 2.2k 2.2× 630 1.1× 462 0.8× 170 0.4× 333 1.2× 93 3.2k
David I. Bellovin United States 16 991 1.0× 448 0.7× 553 1.0× 233 0.5× 164 0.6× 30 1.8k
Eun Sung Park United States 25 1.5k 1.5× 722 1.2× 638 1.1× 155 0.3× 141 0.5× 45 2.6k
Barbara Marte United States 19 2.3k 2.3× 284 0.5× 767 1.4× 484 1.1× 361 1.3× 36 3.0k
Eric J. Kort United States 26 1.3k 1.3× 474 0.8× 606 1.1× 130 0.3× 106 0.4× 55 2.4k
Jean‐Jacques Lebrun Canada 32 2.2k 2.2× 518 0.9× 1.4k 2.5× 201 0.4× 511 1.9× 68 3.6k
Oliver M. Fischer Germany 16 1.4k 1.4× 305 0.5× 1.1k 1.9× 155 0.3× 231 0.9× 25 2.8k
Peter Hein Germany 18 1.2k 1.2× 364 0.6× 688 1.2× 218 0.5× 196 0.7× 34 2.1k

Countries citing papers authored by Jiefeng Cui

Since Specialization
Citations

This map shows the geographic impact of Jiefeng Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiefeng Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiefeng Cui more than expected).

Fields of papers citing papers by Jiefeng Cui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiefeng Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiefeng Cui. The network helps show where Jiefeng Cui may publish in the future.

Co-authorship network of co-authors of Jiefeng Cui

This figure shows the co-authorship network connecting the top 25 collaborators of Jiefeng Cui. A scholar is included among the top collaborators of Jiefeng Cui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiefeng Cui. Jiefeng Cui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhao, Yingying, Jiali Qian, Hanxing Tong, et al.. (2024). TRPV4 drives the progression of leiomyosarcoma by promoting ECM1 generation and co-activating the FAK/PI3K/AKT/GSK3β pathway. Cellular Oncology. 48(2). 455–470. 1 indexed citations
2.
Zhang, Xi, Yingying Zhao, Miao Li, et al.. (2023). A synergistic regulation works in matrix stiffness-driven invadopodia formation in HCC. Cancer Letters. 582. 216597–216597. 14 indexed citations
4.
Li, Miao, Xi Zhang, Mimi Wang, et al.. (2022). Activation of Piezo1 contributes to matrix stiffness‐induced angiogenesis in hepatocellular carcinoma. Cancer Communications. 42(11). 1162–1184. 93 indexed citations
5.
Xu, Yang, Shu-Jung Hsu, Xiahui Lin, et al.. (2022). An SCD1-dependent mechanoresponsive pathway promotes HCC invasion and metastasis through lipid metabolic reprogramming. Molecular Therapy. 30(7). 2554–2567. 63 indexed citations
6.
Wu, Sifan, Xiaoxia Xing, Yaohui Wang, et al.. (2021). The pathological significance of LOXL2 in pre-metastatic niche formation of HCC and its related molecular mechanism. European Journal of Cancer. 147. 63–73. 37 indexed citations
7.
El‐Sahli, Sara, Andrew Sulaiman, Li Li, et al.. (2021). A triple-drug nanotherapy to target breast cancer cells, cancer stem cells, and tumor vasculature. Cell Death and Disease. 12(1). 8–8. 35 indexed citations
8.
Xing, Xiaoxia, Yaohui Wang, Xi Zhang, et al.. (2020). Matrix stiffness‐mediated effects on macrophages polarization and their LOXL2 expression. FEBS Journal. 288(11). 3465–3477. 63 indexed citations
9.
Dong, Gang, Qiongdan Zheng, Min Ma, et al.. (2018). Angiogenesis enhanced by treatment damage to hepatocellular carcinoma through the release of GDF15. Cancer Medicine. 7(3). 820–830. 35 indexed citations
10.
Zhang, Rui, Rongrong Yao, Jinghuan Li, et al.. (2017). Activated hepatic stellate cells secrete periostin to induce stem cell-like phenotype of residual hepatocellular carcinoma cells after heat treatment. Scientific Reports. 7(1). 2164–2164. 30 indexed citations
11.
Xue, Tong‐Chun, Qingan Jia, Yang Bu, et al.. (2014). CXCR7 correlates with the differentiation of hepatocellular carcinoma and suppresses HNF4α expression through the ERK pathway. Oncology Reports. 32(6). 2387–2396. 16 indexed citations
13.
Zou, Yizhuang, Jian Wang, Liangsheng Zhang, et al.. (2010). Cognitive change in schizophrenic patients with concomitant metabolism syndrome. Zhonghua xingwei yixue yu naokexue zazhi. 19(4). 322–324. 2 indexed citations
14.
Zou, Yizhuang, Jiefeng Cui, Jian Wang, et al.. (2009). Clinical reliability and validity of the Chinese version of Measurement and Treatment Research to Improve Cognition in Schizophrenia Consensus Cognitive Battery. Chin J Psychiatry. 42(1). 29–33. 36 indexed citations
15.
Cui, Jiefeng, Yinkun Liu, Haijun Zhou, et al.. (2008). Screening serum hepatocellular carcinoma-associated proteins by SELDI-based protein spectrum analysis. World Journal of Gastroenterology. 14(8). 1257–1257. 13 indexed citations
16.
Cheng, Lei, Liang Zhou, Lei Tao, et al.. (2008). SELDI-TOF MS profiling of serum for detection of laryngeal squamous cell carcinoma and the progression to lymph node metastasis. Journal of Cancer Research and Clinical Oncology. 134(7). 769–776. 17 indexed citations
17.
Guo, Kun, Yan Li, Xiaonan Kang, et al.. (2008). Role of PKCβ in hepatocellular carcinoma cells migration and invasion in vitro: a potential therapeutic target. Clinical & Experimental Metastasis. 26(3). 189–195. 12 indexed citations
18.
Song, Haiyan, Yinkun Liu, Ju-Tao Feng, et al.. (2005). Proteomic analysis on metastasis-associated proteins of human hepatocellular carcinoma tissues. Journal of Cancer Research and Clinical Oncology. 132(2). 92–98. 47 indexed citations
19.
Cui, Jiefeng, et al.. (2004). Studies on peptide acetylation for stable‐isotope labeling after 1‐D PAGE separation in quantitative proteomics. PROTEOMICS. 4(10). 3112–3120. 12 indexed citations
20.
Cui, Jiefeng, Yinkun Liu, Haiyan Song, et al.. (2004). Differential proteomic analysis of human hepatocellular carcinoma cell line metastasis-associated proteins. Journal of Cancer Research and Clinical Oncology. 130(10). 615–22. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026